Pharmacologic treatment of GERD in adolescents: Is esophageal mucosal protection an option?
Open Access
- 17 August 2022
- journal article
- research article
- Published by SAGE Publications in Therapeutic Advances in Gastroenterology
- Vol. 15
Abstract
Background: Gastroesophageal reflux disease (GERD) is still a challenging and difficult to treat condition in children. Although acid suppression represents the mainstay of treatment in adolescents, it is not devoid of adverse events, especially in the long-term. Objectives: In this investigation we explored a new therapeutic avenue in GERD, that is esophageal mucosal protection. Design: To this end, we performed an investigator-initiated, retrospective study to evaluate the efficacy and safety of a short-term treatment with Esoxx™ medical device in 25 adolescents with GERD-related symptoms. This mucoadhesive formulation contains two natural mucopolysaccharides (sodium hyaluronate and chondroitin sulphate) and adheres to the esophageal mucosa, exerting a protective effect against refluxed gastric contents and allowing mucosal healing. Methods: Heartburn, epigastric burning and post-prandial regurgitation were scored with a pain VAS scale and re-evaluated after 3-week treatment with Esoxx (one stick post-prandially, three times daily). Results: All patients completed the treatment without adverse effects and with good tolerability and compliance. All the three major symptoms significantly (p<0.001) improved after treatment. No patient required additional investigation (i.e. upper Gastrointestinal endoscopy) or medication (i.e. antisecretory drugs). Conclusion: The results of this pilot study suggest that esophageal mucosal protection is a promising therapeutic avenue for GERD also in children. Provided, these data be confirmed by a large, randomized clinical trial, this medical device can enter our therapeutic armamentarium against this challenging disease.Keywords
Funding Information
- the Foundation Project of Beijing Research Association for Chronic Disease Prevention and Health Education in 2021 (BJMB0012021025005)
- National Natural Science Foundation of China (81570515)
This publication has 85 references indexed in Scilit:
- Pathophysiology of gastro‐esophageal reflux disease: a role for mucosa integrity?Neurogastroenterology & Motility, 2013
- Barrier effect of Esoxx® on esophageal mucosal damage: experimental study on ex-vivo swine modelClinical and Experimental Gastroenterology, 2012
- Managing gastroesophageal reflux disease in children: The role of endoscopyWorld Journal of Gastrointestinal Endoscopy, 2012
- Topical hyaluronic acid in the management of oral ulcersIndian Journal of Dermatology, 2011
- Immunomodulatory and anti‐inflammatory effects of chondroitin sulphateJournal of Cellular and Molecular Medicine, 2009
- Chondroitin sulphate: A complex molecule with potential impacts on a wide range of biological systemsComplementary Therapies in Medicine, 2009
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studiesBMJ, 2007
- Aluminium absorption and antacid therapy in infancyJournal of Paediatrics and Child Health, 1992
- Abnormalities of gastrointestinal motility in children with nonulcer dyspepsia and in children with gastroesophageal reflux diseaseDigestive Diseases and Sciences, 1991
- Mechanisms of gastroesophageal reflux in childrenThe Journal of Pediatrics, 1980